Voyager Therapeutics, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
VYGR on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
75 Hayden Avenue, Lexington, MA

Insiders trading volume in the past year

Voyager Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Neurocrine Biosciences Inc 10%+ Owner $61.3M Feb 23, 2023
EcoR1 Capital, LLC 10%+ Owner $27.5M Jan 9, 2023
Third Rock Ventures III, L.P. 10%+ Owner $22.8M Feb 2, 2023
Alfred Sandrock President and CEO, Director $3.18M -$217K -6.37% Apr 2, 2024
Peter P. Pfreundschuh Chief Financial Officer $1.31M -$123K -8.57% Feb 21, 2024
Robin Swartz Chief Operating Officer $1.16M -$61.1K -5.02% Apr 2, 2024
Toby Ferguson Chief Medical Officer $1.04M Apr 1, 2024
Omar Khwaja Chief Medical Officer and Head of Research & Development. $862K May 21, 2021
Robert W. Hesslein Senior VP & General Counsel $731K Mar 20, 2023
Jacquelyn Fahey Chief Legal Officer $658K Feb 9, 2024
Todd Carter Chief Scientific Officer $655K -$125K -16% Feb 20, 2024
Julie Burek VP, Finance $375K Mar 21, 2022
James A. Geraghty Director Jun 5, 2024
Catherine J. Mackey Director Jun 5, 2024
Jude Onyia Director Jun 5, 2024
Michael J. Higgins Director Jun 5, 2024
Nancy Vitale Director Jun 5, 2024
Steven Hyman Director Jun 5, 2024
Mark Levin Director, 10%+ Owner Jun 3, 2021
Glenn Pierce Director Jun 5, 2024
George A. Scangos Director Jun 5, 2024
Steven M. Paul Director Jun 3, 2021
Nathan D. Jorgensen Chief Financial Officer Jul 8, 2024
Grace Colon Director Jun 5, 2024

Recent Insider Transactions by Companies or Individuals for Voyager Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.